College of Pharmacy, University of Cincinnati, 3225 Eden Ave., Cincinnati, OH 45267-0004, USA.
J Am Pharm Assoc (2003). 2012 Sep-Oct;52(5):e59-66. doi: 10.1331/JAPhA.2012.11100.
To implement a spirometry-based chronic obstructive pulmonary disease (COPD) screening in a community pharmacy chain, determine whether pharmacists can accurately perform spirometry screenings and interpret results, and determine whether performing screenings improved enrollment in smoking cessation programs.
Prospective study.
Kroger pharmacies in the Cincinnati-Dayton Kroger Marketing Area and off-site screening events in Cincinnati, OH, from March to December 2010.
Consenting individuals older than 35 years who met inclusion and exclusion criteria.
Specially trained community pharmacists administered a validated COPD screening questionnaire and performed spirometry. The results were interpreted, given to the patient, and faxed to the primary care physician. Any patient who was currently smoking was offered smoking cessation counseling.
Spirometry technical quality and interpretation accuracy, screening questionnaire scores in relationship to spirometry results, number of patients enrolled in smoking cessation programs.
Of the 185 patients, 10 were excluded due to inability to perform spirometry. After review, 174 (99%) of the spirometries were judged acceptable and 157 (90%) demonstrated reproducible results. The mean (+/-SD) score on the COPD Population Screener questionnaire was 2.3 ± 1.6 (range 0-8). Airflow limitation (defined as forced expiratory volume in 1 second/forced vital capacity < lower limit of normal) was detected in 16 (9%) of the patients. Although 12 (75%) of these patients were former or current smokers, only 3 (19%) were at increased risk for COPD based on their screening questionnaire scores. Of the nine current smokers who participated in a follow-up interview, two had successfully abstained from smoking for 6 months after the screening and five others had made an attempt to quit.
This study demonstrated that pharmacists are able to perform accurate and reproducible spirometry in a community pharmacy setting.
在社区连锁药店实施基于肺量计的慢性阻塞性肺疾病（COPD）筛查，确定药剂师是否能够准确进行肺量计筛查并解读结果，并确定进行筛查是否能促进更多人参加戒烟计划。
前瞻性研究。
辛辛那提-代顿克罗格营销区的克罗格药店和俄亥俄州辛辛那提的场外筛查活动，时间为 2010 年 3 月至 12 月。
同意参加且符合纳入和排除标准的 35 岁以上个体。
经过专门培训的社区药剂师管理经过验证的 COPD 筛查问卷并进行肺量计检查。结果进行解读，提供给患者，并传真给初级保健医生。任何正在吸烟的患者都被提供戒烟咨询。
肺量计技术质量和解读准确性、与肺量计结果相关的筛查问卷评分、参加戒烟计划的患者人数。
在 185 名患者中，有 10 名因无法进行肺量计检查而被排除。经过审查，174 名（99%）的肺量计检查被认为是可接受的，157 名（90%）显示出可重复的结果。COPD 人群筛查问卷的平均（±SD）得分为 2.3±1.6（范围 0-8）。在 16 名（9%）患者中检测到气流受限（定义为 1 秒用力呼气量/用力肺活量<正常下限）。虽然其中 12 名（75%）患者是前吸烟者或现吸烟者，但仅根据他们的筛查问卷评分，只有 3 名（19%）有患 COPD 的高风险。在 9 名参加随访访谈的现吸烟者中，有 2 人在筛查后成功戒烟 6 个月，另外 5 人尝试戒烟。
这项研究表明，药剂师能够在社区药店环境中进行准确和可重复的肺量计检查。
